Vir Biotechnology (VIR) Stock Highlights

7.34 | -0.41%

2024-12-21 04:08:54

Vir Biotechnology Inc is a commercial-stage immunology company focused on treating and preventing infectious diseases. It has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA, through internal development, collaborations, and acquisitions. The companys pipeline consists of product candidates targeting hepatitis B virus, or HBV, influenza A, human immunodeficiency virus, or HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue and license revenue.

Statistics

Range Today

7.23 7.56

Volume Today 3.75M

Range 1 Year

6.56 13.09

Volume 1 Year 269.19M

Range 3 Year

6.56 58

Volume 3 Year 871.38M

Range 10 Year

6.56 141.01

Volume 10 Year 1.48B

Highlights

Market Capitalization 1.34B (small)

Floating Shares 92.51M

Current Price 7.34

Price To Earnings -2.51

Price To Revenue 6.62

Price To Book 1.06

Earnings Per Share -3.87

Payout Ratio 0%

Performance

Latest -0.41%

1 Month +7%

3 Months -7.21%

6 Months -17.81%

1 Year -26.45%

3 Years -87.34%

5 Years -40.81%

10 Years -54.55%

Benchmarks

Market Capitalization

97 / 368

Gross Profits

11 / 278

Total Revenue

85 / 300

Total Rank

25 / 368

Free Cashflow

347 / 352

Performance 5 years

160 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.